Mass General researcher Matt Rosen, PhD, is all too familiar with the devastating effects of a late breast cancer diagnosis.
Read more
[ultimate_heading main_heading=”The Latest in Cancer” heading_tag=”h1″ alignment=”left” main_heading_font_family=”font_family:|font_call:” main_heading_style=”font-weight:900;” main_heading_font_size=”desktop:44px;” sub_heading_font_family=”font_family:|font_call:” sub_heading_style=”font-weight:700;” sub_heading_font_size=”desktop:20px;”][/ultimate_heading]
The unrestricted funding provided by the MGH Research Scholar awards is enabling creative new approaches to cancer research.
Read more
Read more
A recent study both validated time to surgery as a standardized metric for breast cancer care and identified a worrying difference in time to surgery between Black and white patients.
Read more
Read more
How Daniel Faden, MD, and his team are working on developing and applying blood based cancer diagnostic tools.
Read more
Read more
It took contributions from almost 100 people to translate promising lab findings into a first-in-human treatment for glioblastoma.
Read more
Read more
Genevieve Boland, MD, PhD, a physician-investigator in the Cancer Center at Mass General, is researching skin cancer and related diseases.
Read more
Read more
A close-up look at the Demehri Lab and how they are working to understand the immune system’s role in early cancer development.
Read more
Read more
A Mass General oncologist has designed an iPad app to help patients navigate the challenges of acute myeloid leukemia treatment.
Read more
Read more
Dr. Bahl is using artificial intelligence (AI) and deep learning (DL) to improve the detection, diagnosis, and treatment of breast cancer.
Read more
Read more
The findings highlight the need for more initiatives to recruit and retain individuals from underrepresented groups.
Read more
Read more
Researchers have identified a promising new strategy to reduce a debilitating side effect of radiation treatment for cancer.
Read more
Read more
Researchers are worried that delayed cancer screenings due to COVID could lead to later diagnoses and more severe cases.
Read more
Read more